Next Article in Journal
Metabolic Adaptation and Protein Complexes in Prokaryotes
Next Article in Special Issue
Comparative Analysis of End Point Enzymatic Digests of Arabino-Xylan Isolated from Switchgrass (Panicum virgatum L) of Varying Maturities using LC-MSn
Previous Article in Journal
Ensemble Kinetic Modeling of Metabolic Networks from Dynamic Metabolic Profiles
Previous Article in Special Issue
Structural Identification of O-Linked Oligosaccharides Using Exoglycosidases and MSn Together with UniCarb-DB Fragment Spectra Comparison
Open AccessReview

Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches

Gynecological Research Group, Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland
*
Author to whom correspondence should be addressed.
Metabolites 2012, 2(4), 913-939; https://doi.org/10.3390/metabo2040913
Received: 31 October 2012 / Revised: 8 November 2012 / Accepted: 9 November 2012 / Published: 14 November 2012
(This article belongs to the Special Issue Glycomics and Glycoproteomics)
Glycans are important partners in many biological processes, including carcinogenesis. The rapidly developing field of functional glycomics becomes one of the frontiers of biology and biomedicine. Aberrant glycosylation of proteins and lipids occurs commonly during malignant transformation and leads to the expression of specific tumor-associated glycans. The appearance of aberrant glycans on carcinoma cells is typically associated with grade, invasion, metastasis and overall poor prognosis. Cancer-associated carbohydrates are mostly located on the surface of cancer cells and are therefore potential diagnostic biomarkers. Currently, there is increasing interest in cancer-associated aberrant glycosylation, with growing numbers of characteristic cancer targets being detected every day. Breast and ovarian cancer are the most common and lethal malignancies in women, respectively, and potential glycan biomarkers hold promise for early detection and targeted therapies. However, the acceleration of research and comprehensive multi-target investigation of cancer-specific glycans could only be successfully achieved with the help of a combination of novel high-throughput glycomic approaches. View Full-Text
Keywords: carbohydrate; malignancy; anti-glycan antibodies; tumor marker; microarray; glycomics; breast cancer; ovarian cancer carbohydrate; malignancy; anti-glycan antibodies; tumor marker; microarray; glycomics; breast cancer; ovarian cancer
Show Figures

Figure 1

MDPI and ACS Style

Pochechueva, T.; Jacob, F.; Fedier, A.; Heinzelmann-Schwarz, V. Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches. Metabolites 2012, 2, 913-939.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop